ArticleUpdates in surgery2026
Surgical management of pediatric primary splenic lesions: safety and feasibility of transumbilical single-port laparoscopic partial splenectomy.
Article in Updates in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study retrospectively analyzed the clinical characteristics of pediatric patients with primary splenic lesions and evaluated the safety and efficacy of partial splenectomy as a spleen-preserving surgical approach. Emphasis was placed on assessing the feasibility and cosmetic outcomes of transumbilical single-port laparoscopic partial splenectomy.
methodsA total of 23 pediatric patients with primary splenic diseases were treated at a single institution between January 2014 and December 2024. Clinical presentations, imaging findings, surgical techniques, pathological diagnoses, perioperative complications, and postoperative platelet trends were reviewed. Patients were categorized into three groups based on the surgical approach: conventional laparoscopic partial splenectomy (CL group), transumbilical single-port laparoscopic partial splenectomy with an auxiliary port (SPL + 1 group), and pure transumbilical single-port laparoscopic partial splenectomy (SPL group). Surgical and postoperative outcomes were compared among these groups.
resultsThe cohort consisted of 16 boys and 7 girls, with ages ranging from 1.4 to 14 years at the time of surgery. Clinical presentations included abdominal distension (n = 2), hematemesis (n = 1), and bicytopenia (n = 1), while the remaining 19 cases were incidentally detected via imaging. Lesion diameters ranged from 2.2 to 8.1 cm. Pathological diagnoses included vascular malformation (10/23), splenic cyst (6/23), littoral cell angioma (5/23), hamartoma (1/23), and wandering spleen (1/23). Partial splenectomy was performed either through open surgery or minimally invasive techniques (CL, SPL + 1, or SPL approaches). Among the minimally invasive groups, significant differences (P < 0.05) were observed in hospitalization costs, peak postoperative platelet count, and scar assessment scores (Patient and Observer Scar Assessment Scale, patient/parent version). The most common postoperative complication was localized fluid collection in the abdominal, pelvic, or perisplenic regions.
conclusionsVascular malformations, splenic cysts, and littoral cell angiomas are the most common primary splenic lesions in children. Partial splenectomy is a safe and effective spleen-preserving treatment. Notably, transumbilical single-port laparoscopic partial splenectomy is minimally invasive and offers superior cosmetic results, making it particularly suitable for pediatric patients.
Indexed as
Identifiers
41975166What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.